These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 27202318)

  • 1. A Systematic Review of Health State Utility Values for Advanced Ovarian Cancer.
    Al-Dakkak I; Borrill J; Murphy E; Posnett J; Zhang Y
    Value Health; 2014 Nov; 17(7):A645. PubMed ID: 27202318
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-state utility values in breast cancer.
    Peasgood T; Ward SE; Brazier J
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):553-66. PubMed ID: 20950071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on lymphadenectomy in early and advanced ovarian cancer.
    Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putting the 'Q' in quality adjusted life years (QALYs) for advanced ovarian cancer - An approach using data clustering methods and the internet.
    Stein K; Sugar C; Velikova G; Stark D
    Eur J Cancer; 2007 Jan; 43(1):104-13. PubMed ID: 17095206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-State Utility Values in Breast And Prostate Cancer Measured using the EQ-5D: A Systematic Review of the Literature.
    Hughes R; Mitchell CR; Bishop RS; Fotheringham I
    Value Health; 2014 Nov; 17(7):A645-6. PubMed ID: 27202320
    [No Abstract]   [Full Text] [Related]  

  • 6. Health state utility scores in advanced non-small cell lung cancer.
    Doyle S; Lloyd A; Walker M
    Lung Cancer; 2008 Dec; 62(3):374-80. PubMed ID: 18467000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating Health State Utility Values from Fact-Ovarian Data Collected in a Phase Ii Maintenance Study in Platinum Sensitive Recurrent Ovarian Cancer (Study 19): A Comparison of Mapping Algorithms.
    Hettle R; Borrill J; Suri G; Wulff J
    Value Health; 2014 Nov; 17(7):A646. PubMed ID: 27202324
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic searching and selection of health state utility values from the literature.
    Papaioannou D; Brazier J; Paisley S
    Value Health; 2013 Jun; 16(4):686-95. PubMed ID: 23796303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting.
    Chouaid C; Agulnik J; Goker E; Herder GJ; Lester JF; Vansteenkiste J; Finnern HW; Lungershausen J; Eriksson J; Kim K; Mitchell PL
    J Thorac Oncol; 2013 Aug; 8(8):997-1003. PubMed ID: 23787802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of retroperitoneal lymphadenectomy in advanced epithelial ovarian cancer].
    Jaffré I; Bordes V; Dejode M; Dravet F; Classe JM
    Bull Cancer; 2010 Jan; 97(1):65-71. PubMed ID: 19995689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does cancer risk affect health-related quality of life in patients with Barrett's esophagus?
    Gerson LB; Ullah N; Hastie T; Goldstein MK
    Gastrointest Endosc; 2007 Jan; 65(1):16-25. PubMed ID: 17185075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.
    Camara O; Sehouli J
    Anticancer Res; 2009 Jul; 29(7):2837-43. PubMed ID: 19596971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early symptoms of ovarian cancer: a case-control study without recall bias.
    Friedman GD; Skilling JS; Udaltsova NV; Smith LH
    Fam Pract; 2005 Oct; 22(5):548-53. PubMed ID: 15964871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
    Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
    J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal surgery in advanced ovarian cancer.
    Takahashi O; Tanaka T
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):10-4. PubMed ID: 17218845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between tumor size and stage in early versus advanced ovarian cancer.
    Horvath LE; Werner T; Boucher K; Jones K
    Med Hypotheses; 2013 May; 80(5):684-7. PubMed ID: 23474070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
    Calhoun EA; Fishman DA; Lurain JR; Welshman EE; Bennett CL
    Gynecol Oncol; 2004 Apr; 93(1):164-9. PubMed ID: 15047231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer.
    Lairson DR; Parikh RC; Cormier JN; Du XL
    Value Health; 2014; 17(1):34-42. PubMed ID: 24438715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined population genomic screening for three high-risk conditions in Australia: a modelling study.
    Lacaze P; Marquina C; Tiller J; Brotchie A; Kang YJ; Merritt MA; Green RC; Watts GF; Nowak KJ; Manchanda R; Canfell K; James P; Winship I; McNeil JJ; Ademi Z
    EClinicalMedicine; 2023 Dec; 66():102297. PubMed ID: 38192593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health state utility values by cancer stage: a systematic literature review.
    Pourrahmat MM; Kim A; Kansal AR; Hux M; Pushkarna D; Fazeli MS; Chung KC
    Eur J Health Econ; 2021 Nov; 22(8):1275-1288. PubMed ID: 34125315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.